Dermata Therapeutics Inc. (DRMAW)
NASDAQ: DRMAW
· Real-Time Price · USD
0.02
0.00 (29.03%)
At close: Jun 09, 2025, 3:06 PM
Dermata Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -0.6 | -0.17 | -0.2 | -0.14 | -0.22 | -4.21 | -7.37 | -9.84 | -0.14 | -11.92 | -10.05 | -9.99 | -14.01 | -341.58 | -48.95 | -109.83 | -70.33 |
PEG Ratio | 0.01 | n/a | 0.00 | 0.00 | -0.00 | n/a | 0.52 | 0.10 | -0.00 | 0.36 | 0.49 | 0.37 | -0.01 | 3.62 | -0.52 | 3.06 | -0.01 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0.76 | 1.34 | 0.54 | 0.47 | 0.73 | 5.66 | 7.91 | 8.34 | 0.16 | 12.55 | 12.82 | 11.30 | 19.89 | 345.10 | 7.30 | -1.16K | 910.65 |
P/FCF Ratio | -2.88 | -0.72 | -0.75 | -0.73 | -1.03 | -31.35 | -28.62 | -36.38 | -0.77 | -41.41 | -37.39 | -59.34 | -59.88 | -1.93K | -151.77 | -647.8 | -835.31 |
P/OCF Ratio | -2.88 | -0.72 | -0.75 | -0.73 | -1.03 | -31.35 | -28.62 | -36.38 | -0.77 | -41.41 | -37.39 | -59.34 | -59.88 | -1.93K | -151.77 | -647.8 | -835.31 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -0.35 | 0.25 |
Quick Ratio | 6.97 | 1.79 | 3.44 | 2.73 | 3.78 | 4.91 | 7.99 | 12.76 | 7.70 | 7.53 | 5.97 | 8.07 | 7.59 | 7.66 | 11.45 | 0.69 | 1.76 |
Current Ratio | 6.97 | 1.79 | 3.44 | 2.73 | 3.78 | 4.91 | 7.99 | 12.76 | 7.70 | 7.53 | 5.97 | 8.07 | 7.59 | 7.66 | 11.45 | 0.69 | 1.76 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | -59.13 | n/a | n/a | n/a | -40.67 | -113.84 | n/a | n/a | -0.06 | -2.63K | -729.55 | -52.43 |
Return on Equity | -0.32 | -2.02 | -0.67 | -0.85 | -0.82 | -0.34 | -0.27 | -0.21 | -0.28 | -0.26 | -0.32 | -0.28 | -0.35 | -0.25 | -0.04 | 2.63 | -3.24 |
Return on Assets | -0.23 | -0.89 | -0.47 | -0.54 | -0.61 | -0.27 | -0.23 | -0.2 | -0.24 | -0.23 | -0.27 | -0.25 | -0.31 | -0.22 | -0.13 | -1.17 | -1.4 |
Return on Invested Capital | -0.28 | -4.13 | -0.68 | -0.87 | 0.02 | n/a | -0.28 | -0.22 | -0.28 | n/a | -0.32 | n/a | n/a | 0.05 | -0.14 | -3.83 | -1.96 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |